Figure 5.
Figure 5. Replicative history of CD4+ T-cell populations defined by the expression of CD45RA, CCR7, and CD25. CD4+ T cells were separated into conventional CD4+CD25– (1), CD4+CD25low (2), and regulatory CD4+CD25highT cells (3) defined by their expression of CD25. These subsets were further sorted according to their CD45RA and CCR7 expression in 3 subsets each, namely Tnaive (CD45RA+CCR7+), TCM (CD45RA–CCR7+), and TEM cells (CD45RA–CCR7–). These CD4+ T-cell subsets were then assessed for TREC content. Genomic DNA of sorted subsets was isolated, and the number of TRECs was determined by quantitative real-time PCR. Data are shown as the mean values obtained for 2 independent donors and 2 MM patients. Error bars represent SD. (A) Conventional CD4+CD25–, (B) CD4+CD25low, and (C) CD4+CD25highT cells from 2 healthy individuals. (D) Conventional CD4+CD25–, (E) CD4+CD25low, and (F) CD4+CD25highT cells from 2 MM patients.

Replicative history of CD4+ T-cell populations defined by the expression of CD45RA, CCR7, and CD25. CD4+ T cells were separated into conventional CD4+CD25 (1), CD4+CD25low (2), and regulatory CD4+CD25highT cells (3) defined by their expression of CD25. These subsets were further sorted according to their CD45RA and CCR7 expression in 3 subsets each, namely Tnaive (CD45RA+CCR7+), TCM (CD45RACCR7+), and TEM cells (CD45RACCR7). These CD4+ T-cell subsets were then assessed for TREC content. Genomic DNA of sorted subsets was isolated, and the number of TRECs was determined by quantitative real-time PCR. Data are shown as the mean values obtained for 2 independent donors and 2 MM patients. Error bars represent SD. (A) Conventional CD4+CD25, (B) CD4+CD25low, and (C) CD4+CD25highT cells from 2 healthy individuals. (D) Conventional CD4+CD25, (E) CD4+CD25low, and (F) CD4+CD25highT cells from 2 MM patients.

Close Modal

or Create an Account

Close Modal
Close Modal